References
- Reviewofophthalmology.com [homepage on the Internet]SinghACunninghamETStewartJMDetection and Treatment of Ocular Toxocariasis2007 Available from: http://www.reviewofophthalmology.com/content/d/retinal_insider/i/1297/c/24974/Accessed April 13, 2015
- GeraintJZumlaAThe Granulomatous DisordersUKCambridge University Press1999
- BergerSInfectious Diseases of Australia [Internet]Los AngelesGIDEON Informatics2014 [cited November 19, 2014]. Available from: https://books.google.com.au/books?id=Vv59BwAAQBAJ&pg=PA3&dq=Infectious+diseases+of+Australia&hl=en&sa=X&ei=WBg7Vd2rN6a5mwWrnoHQAw&ved=0CB0Q6AEwAA#v=onepage&q=Infectious%20diseases%20of%20Australia&f=falseAccessed April 25, 2015
- RoldanWHEspinozaYAAtuncarAOrtegaEMartinezASaraviaMFrequency of eosinophilia and risk factors and their association with toxocara infection in schoolchildren during a health survey in the north of Lima, PeruRev Inst Med Trop Sao Paulo200850527327818949344
- Al-MoslihMSerological Diagnosis of Certain Human, Animal and Plant DiseasesCroatiaIntech2012
- JacquierPGottstienBStingelinYEckertJImmunodiagnosis of toxo-carosis in humans: evaluation of a new enzyme-linked immunosorbent assay kitJ Clin Microbiol1991299183118351774303
- BruschiFHelminth Infections and their Impact on Global Public HealthNew YorkSpringer2014
- FosterCSVitaleATDiagnosis and Treatment of Uveitis2nd edNew DelhiJaypee Brothers Medical Publishers2013
- LyallDAHutchisonBMGaskellAVarikkaraMIntravitreal Ranibi-zumab in the treatment of choroidal neovascularization secondary to ocular toxocariasis in a 13-year-old boyEye (Lond)201024111730173120930857
- Informahealthcare.com [homepage on the Internet]KianersiFBeniANBeniZNGhanbariHIntravitreal bevacizumab for treatment of choroidal neovascularization secondary to toxoplasmic retinochoroiditis: a case series2013 Available from: http://informahealthcare.com/doi/abs/10.3109/08820538.2013.838278Accessed April 13, 2015
- The Pharmaceutical Benefit Scheme [homepage on the Internet]Ranibizumab, solution for intravitreal injection, 2.3 mg in 0.23 mL, Lucentis®2012 Available from: http://www.pbs.gov.au/info/industry/listing/elements/pbac-meetings/psd/2012-11/ranibizumab-lucentisAccessed April 13, 2015